Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
The Cleveland Clinic |
---|---|
Information provided by: | The Cleveland Clinic |
ClinicalTrials.gov Identifier: | NCT00271050 |
The purpose of the research study is to learn whether external beam radiation can be used as a safe and effective treatment for patients with bulky (≥ 5cm) sites of non-Hodgkin's lymphoma prior to treatment with 90Y-ibritumomab tiuxetan (Zevalin).
Condition | Intervention | Phase |
---|---|---|
Lymphoma, B-Cell |
Procedure: external beam radiotherapy |
Phase I |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study |
Official Title: | The Role of Conformal External Beam Radiotherapy in the Management of Patients With Bulky Disease Undergoing Y90-Ibritumomab Tiuxetan (Zevalin) Radio-Immunotherapy for Indolent B-Cell Non-Hodgkin's Lymphoma |
Estimated Enrollment: | 12 |
Study Start Date: | December 2005 |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Roger Macklis, MD | 216-444-5576 | macklir@ccf.org |
Contact: Ruth Cocirteu, RN | 216-445-5053 | cocirtr@ccf.org |
United States, Ohio | |
Cleveland Clinic | Recruiting |
Cleveland, Ohio, United States, 44195 |
Principal Investigator: | Roger Macklis, MD | Cleveland Clinic |
Study ID Numbers: | IRB 7883, CCF IRB 7883, Case 1405 |
Study First Received: | December 28, 2005 |
Last Updated: | December 28, 2005 |
ClinicalTrials.gov Identifier: | NCT00271050 |
Health Authority: | United States: Institutional Review Board |
non-Hodgkin's lymphoma external beam radiotherapy (EBRT) radio-immunotherapy (RIT) Zevalin |
Lymphoma, B-Cell Lymphatic Diseases Immunoproliferative Disorders B-cell lymphomas |
Lymphoma, small cleaved-cell, diffuse Lymphoproliferative Disorders Lymphoma, Non-Hodgkin Lymphoma |
Neoplasms Neoplasms by Histologic Type Immune System Diseases |